Orlistat improves on the features of metabolic syndrome in obese patients with type 2 diabetes

被引：0
|
作者：
Oh, S
Park, CY
Woo, JT
Kim, YS
Son, HY
Lee, HC
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A595 / A595
页数：1
相关论文
共 50 条
  • [31] Latin-American multicentric study with orlistat in overweight or obese patients with type 2 diabetes
    Halpern, A
    DIABETES, 2001, 50 : A437 - A437
  • [32] Orlistat (xenical®) reduces cardiovascular disease risk factors in obese patients with type 2 diabetes
    Hollander, P
    Lucas, C
    Segal, KR
    DIABETOLOGIA, 1998, 41 : A126 - A126
  • [33] Effects of weight reduction with orlistat on cardiovascular risk in obese hyertensive patients with type 2 diabetes
    Uehara, MH
    Peres, RB
    Ferreira, SRG
    Zanella, MT
    HYPERTENSION, 2001, 37 (03) : 1042 - 1042
  • [34] Bariatric Surgery Improves the Metabolic Profile of Morbidly Obese Patients With Type 1 Diabetes
    Brethauer, Stacy A.
    Aminian, Ali
    Rosenthal, Raul J.
    Kirwan, John P.
    Kashyap, Sangeeta R.
    Schauer, Philip R.
    DIABETES CARE, 2014, 37 (03) : E51 - E52
  • [35] Orlistat promotes weight loss and improves glycaemic control in overweight patients with type 2 diabetes
    Hanefeld, M
    Platon, J
    Sachse, G
    DIABETOLOGIA, 2001, 44 : A231 - A231
  • [36] Weight loss improves features of the metabolic syndrome in overweight and obese women
    LeCheminant, JD
    Stewart, E
    Sullivan, D
    Gibson, C
    Bailey, B
    Smith, B
    Hall, M
    Jacobsen, D
    Donnelly, J
    FASEB JOURNAL, 2005, 19 (04): : A46 - A46
  • [37] Orlistat: Current issues for patients with type 2 diabetes
    Mancino J.M.
    Current Diabetes Reports, 2006, 6 (5) : 389 - 394
  • [38] Positive effect of Orlistat on controlling blood glucose levels in overweight and obese patients with Type 2 diabetes
    Valensi, P
    Eschwège, E
    Drouin, P
    Gin, H
    Joubert, J
    Guy-Grand, B
    DIABETOLOGIA, 2002, 45 : A220 - A220
  • [39] XENDOS: Onset of type 2 diabetes in obese patients with normal glucose tolerance/IGT and metabolic syndrome
    Defronzo, R
    Sjostrom, L
    Torgerson, J
    Boldrin, J
    Hauptman, J
    DIABETES, 2003, 52 : A393 - A393
  • [40] Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes
    Hickman, Ingrid J.
    Whitehead, Jonathan P.
    Prins, Johannes B.
    Macdonald, Graeme A.
    DIABETES OBESITY & METABOLISM, 2007, 9 (03): : 438 - 440
12345